المؤلفون: Malzbender, K, Barbarino, P, Ferrell, PB, Bradshaw, A, Brookes, AJ, Diaz, C, van der Flier, WM, Georges, J, Hansson, O, Hartmanis, M, Jonsson, L, Krishnan, R, MacLeod, T, Mangialasche, F, Mecocci, P, Minguillon, C, Middleton, L, Pla, S, Sardi, SP, Scholl, M, Suarez-Calvet, M, Weidner, W, Visser, PJ, Zetterberg, H, Bose, N, Solomon, A, Kivipelto, M

المصدر: The journal of prevention of Alzheimer's disease. 11(2):329-338

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:154885760

المؤلفون: Cortes J; Department of Medicine, Georgia Cancer Center, Augusta University, Augusta, GA, USA., Jonas BA; Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA, USA., Schiller G; Department of Internal Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Mims A; Division of Hematology, The Ohio State University, Columbus, OH, USA., Roboz GJ; Department of Hematology and Medical Oncology, Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA., Wei AH; Department of Haematology, The Alfred Hospital, Melbourne, Australia., Montesinos P; Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Ferrell PB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Yee KW; Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France., Schwarer A; Department of Hematology, Box Hill Hospital, Monash University and Eastern Health Clinical School, Melbourne, Australia., Watts JM; Division of Hematology, Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1145-1152. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Isocitrate Dehydrogenase*/genetics , Isocitrate Dehydrogenase*/antagonists & inhibitors , Bridged Bicyclo Compounds, Heterocyclic*/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic*/adverse effects , Sulfonamides*/therapeutic use , Sulfonamides*/adverse effects , Mutation*, Humans ; Middle Aged ; Female ; Male ; Aged ; Adult ; Pyridines/therapeutic use ; Pyridines/adverse effects ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Remission Induction ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/adverse effects ; Drug Resistance, Neoplasm/genetics ; Aged, 80 and over

المؤلفون: Heimlich JB; Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Bhat P; Vanderbilt University School of Medicine, Nashville, TN., Parker AC; Vanderbilt University School of Medicine, Nashville, TN., Jenkins MT; Vanderbilt University School of Medicine, Nashville, TN., Vlasschaert C; Department of Medicine, Queen's University, Kingston, ON, Canada., Ulloa J; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Van Amburg JC; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Potts CR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Olson S; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Silver AJ; Vanderbilt University School of Medicine, Nashville, TN., Ahmad A; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Sharber B; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Brown D; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Hu N; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., van Galen P; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA., Savona MR; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Vanderbilt-Ingram Cancer Center, Program in Cancer Biology, and Center for Immunobiology, Nashville, TN.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN., Bick AG; Division of Genomic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Ferrell PB; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.

المصدر: Blood advances [Blood Adv] 2024 Jul 23; Vol. 8 (14), pp. 3665-3678.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Clonal Hematopoiesis* , Inflammation*/genetics, Humans ; Genotype ; Mutation ; Gene Expression Profiling ; Dioxygenases ; DNA Methyltransferase 3A/metabolism ; Male ; Female ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism

المؤلفون: Shannon ML; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Heimlich JB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Olson S; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Debevec A; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Copeland Z; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Kishtagari A; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Vlasschaert C; Department of Medicine, Queen's University, Kingston, ON, Canada., Snider C; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Silver AJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN., Brown D; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Spaulding T; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Bhatta M; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Pugh K; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Stockton SS; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Ulloa J; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Xu Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN., Baljevic M; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Moslehi J; Section of Cardio-Oncology & Immunology, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA., Jahangir E; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Ferrell PB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN., Slosky D; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Bick AG; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN., Savona MR; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN.

المصدر: Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3453-3463.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Clonal Hematopoiesis* , Inflammation*, Humans ; Prospective Studies ; Female ; Male ; Middle Aged ; Aged ; Registries ; Hematologic Neoplasms/genetics ; Mutation ; Adult

المؤلفون: Tentori CA; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy.; Comprehensive Cancer Centre, King's College London UK., Zhao LP; Hématologie seniors Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP) Paris France.; INSERM UMR_S1160, Institut de Recherche Saint Louis Université Paris Cité Paris France., Tinterri B; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Strange KE; Comprehensive Cancer Centre, King's College London UK.; Research Group of Molecular Immunology Francis Crick Institute London UK., Zoldan K; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Dimopoulos K; Department of Clinical Biochemistry Bispebjerg and Frederiksberg Hospital Copenhagen Denmark.; Department of Pathology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark., Feng X; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Riva E; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Lim B; Imperial College London London UK., Simoni Y; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France., Murthy V; Centre for Clinical Haematology, University Hospitals of Birmingham Birmingham UK., Hayes MJ; Cell & Developmental Biology Vanderbilt University School of Medicine Nashville Tennessee USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA., Poloni A; Department of Clinical and Molecular Sciences Università Politecnica delle Marche Ancona Italy., Padron E; Moffitt Cancer Center, Malignant Hematology Department Tampa USA., Cardoso BA; Universidade Católica Portuguesa Faculdade de Medicina Portugal.; Universidade Católica Portuguesa, Centro de Investigação Interdisciplinar em Saúde Portugal., Cross M; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Winter S; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Santaolalla A; Comprehensive Cancer Centre, King's College London UK., Patel BA; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Groarke EM; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Wiseman DH; Division of Cancer Sciences The University of Manchester Manchester UK.; The Christie NHS Foundation Trust Manchester UK., Jones K; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Jamieson L; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Manogaran C; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Daver N; University of Texas MD Anderson Cancer Center Houston, Texas USA., Gallur L; Hematology Department, Vall d'hebron University Hospital, Vall d'hebron Institut of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain., Ingram W; Department of Haematology University Hospital of Wales Cardiff UK., Ferrell PB; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt University Medical Center Nashville Tennessee USA., Sockel K; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Dulphy N; INSERM UMR_S1160, Institut de Recherche Saint Louis Université Paris Cité Paris France.; Laboratoire d'Immunologie et d'Histocompatibilité, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Saint-Louis Paris France.; Institut Carnot OPALE, Institut de Recherche Saint-Louis, Hôpital Saint-Louis Paris France., Chapuis N; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France.; Assistance Publique-Hôpitaux de Paris Centre, Hôpital Cochin Paris France., Kubasch AS; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Olsnes AM; Section for Hematology, Department of Medicine Haukeland University Hospital Bergen Norway.; Department of Clinical Science Faculty of Medicine, University of Bergen Bergen Norway., Kulasekararaj A; Department of Haematology King's College Hospital, Denmark Hill London UK., De Lavellade H; Haematology Department Guy's and St Thomas NHS Trust London UK., Kern W; MLL Münchner Leukämielabor Munich Germany., Van Hemelrijck M; Comprehensive Cancer Centre, King's College London UK., Bonnet D; Hematopoietic Stem Cell Laboratory Francis Crick Institute London UK., Westers TM; Department of Hematology, Cancer Center Amsterdam Amsterdam University Medical Centers, location VU University Medical Center Amsterdam The Netherlands., Freeman S; Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK., Oelschlaegel U; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Valcarcel D; Hematology Department, Vall d'hebron University Hospital, Vall d'hebron Institut of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain., Raddi MG; Myelodysplastic Syndrome Unit, Hematology Division Azienda Ospedaliero-Universitaria Careggi, University of Florence Florence Italy., Grønbæk K; Department of Hematology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark.; Biotech Research and Innovation Center (BRIC) University of Copenhagen Copenhagen Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark., Fontenay M; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France.; Assistance Publique-Hôpitaux de Paris Centre, Hôpital Cochin Paris France., Loghavi S; University of Texas MD Anderson Cancer Center Houston, Texas USA., Santini V; Myelodysplastic Syndrome Unit, Hematology Division Azienda Ospedaliero-Universitaria Careggi, University of Florence Florence Italy., Almeida AM; Hematology Department Hospital da Luz Lisboa Lisboa Portugal.; Deanery Faculdade de Medicina, UCP Lisboa Portugal., Irish JM; Cell & Developmental Biology Vanderbilt University School of Medicine Nashville Tennessee USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA., Sallman DA; Moffitt Cancer Center, Malignant Hematology Department Tampa USA., Young NS; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., van de Loosdrecht AA; Department of Hematology, Cancer Center Amsterdam Amsterdam University Medical Centers, location VU University Medical Center Amsterdam The Netherlands., Adès L; Hématologie seniors Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP) Paris France.; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France., Della Porta MG; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Cargo C; Leeds Teaching Hospital Leeds UK., Platzbecker U; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Kordasti S; Comprehensive Cancer Centre, King's College London UK.; Department of Clinical and Molecular Sciences Università Politecnica delle Marche Ancona Italy.; Haematology Department Guy's and St Thomas NHS Trust London UK.

مؤلفون مشاركون: i4MDS consortium

المصدر: HemaSphere [Hemasphere] 2024 May 15; Vol. 8 (5), pp. e64. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

المؤلفون: Kishtagari A; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Khan MAW; Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Li Y; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA., Vlasschaert C; Department of Medicine, Queen's University, Kingston, ON, Canada., Marneni N; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Silver AJ; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, USA., von Beck K; Vanderbilt University School of Medicine, Nashville, TN, USA., Spaulding T; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Stockton S; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Snider C; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Sochacki A; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Dorand D; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Mack TM; Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Ferrell PB Jr; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Xu Y; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.; Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, TN, USA.; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA., Bejan CA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA., Savona MR; Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN, USA. michael.savona@vanderbilt.edu.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. michael.savona@vanderbilt.edu.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, USA. michael.savona@vanderbilt.edu.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, TN, USA. michael.savona@vanderbilt.edu., Bick AG; Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. alexander.bick@vumc.org.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, USA. alexander.bick@vumc.org.

المصدر: Blood cancer journal [Blood Cancer J] 2024 Jan 15; Vol. 14 (1), pp. 6. Date of Electronic Publication: 2024 Jan 15.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Clonal Hematopoiesis* , Hematologic Neoplasms*/genetics, Humans ; Mutation ; Point Mutation ; Chromosome Aberrations

المؤلفون: Moyo TK; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Levine Cancer Institute, Charlotte, North Carolina., Kishtagari A; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Villaume MT; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., McMahon B; University of Colorado, Denver, Colorado., Mohan SR; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Stopczynski T; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Chen SC; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Fan R; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Huo Y; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee., Moon H; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee., Tang Y; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Bejan CA; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Childress M; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Anderson I; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Rawling K; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Simons RM; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Moncrief A; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Caza R; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Dugger L; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Collins A; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Dudley CV; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Ferrell PB; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee., Byrne M; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Strickland SA; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Ayers GD; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Quantitative Sciences, Vanderbilt University, Nashville, Tennessee., Landman BA; Department of Electrical and Computer Engineering, Vanderbilt University School of Medicine, Nashville, Tennessee.; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee., Mason EF; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee., Mesa RA; Wake Forest Baptist Cancer Center, Winston-Salem, North Carolina., Palmer JM; Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona., Michaelis LC; Medical College of Wisconsin, Madison, Wisconsin., Savona MR; Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.; Center for Immunobiology, Vanderbilt University School of Medicine, Nashville, Tennessee.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jul 05; Vol. 29 (13), pp. 2375-2384.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*/drug therapy , Primary Myelofibrosis*/metabolism , Janus Kinase Inhibitors*/therapeutic use, Humans ; Aged ; Phosphatidylinositol 3-Kinases ; Pyrimidines/therapeutic use ; Nitriles/therapeutic use

المؤلفون: Ferrell PB; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Fillit H; Alzheimer's Drug Discovery Foundation and Icahn School of Medicine at Mount Sinai, New York, New York, USA., Neumann PJ; Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, Massachusetts, USA., Wall JK; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Murray JF; Davos Alzheimer's Collaborative, Wayne, Pennsylvania, USA.

المصدر: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2023 Apr; Vol. 19 (4), pp. 1558-1567. Date of Electronic Publication: 2022 Nov 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE

مواضيع طبية MeSH: Alzheimer Disease*/diagnosis, Humans ; Technology ; Inventions

المؤلفون: von Beck K; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., von Beck T; Program in Immunology and Molecular Pathogenesis, Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA., Ferrell PB Jr; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Bick AG; Division of Genetic Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Kishtagari A; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. ashwin.kishtagari@vumc.org.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Jan 04; Vol. 13 (1), pp. 5. Date of Electronic Publication: 2023 Jan 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms* , Myeloproliferative Disorders*/pathology , Hematologic Diseases*, Humans ; Clonal Hematopoiesis/genetics ; Hematopoiesis/genetics ; Hematopoietic Stem Cells/pathology ; Mutation

المؤلفون: Watts JM; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA. Electronic address: jxw401@miami.edu., Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Yang J; Karmanos Cancer Institute, Detroit, MI, USA., Prebet T; Department of Hematology, Yale University, New Haven, CT, USA., Lee S; Department of Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA., Schiller GJ; David Geffen School of Medicine at University of California, Los Angeles, CA, USA., Dinner SN; Department of Hematology and Oncology, Northwestern University, Chicago, IL, USA., Pigneux A; Centre Hospitalier Universitaire Bordeaux, Bordeaux, France., Montesinos P; Hospital Universitari i Politècnic La Fe, Valencia, Spain., Wang ES; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Seiter KP; New York Medical College, New York, NY, USA., Wei AH; The Alfred Hospital and Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., De Botton S; Institut Gustave-Roussy, Villejuif, France., Arnan M; Institut Català d'Oncologia-Hospital Duran i Reynals, IDIBELL, Hospitalet Llobregat, Barcelona, Spain., Donnellan W; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, TN, USA., Schwarer AP; Eastern Health Monash University Clinical School and Austin Hospital, Melbourne, Australia., Récher C; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Jonas BA; University of California, Davis Comprehensive Cancer Center, Sacramento, CA, USA., Ferrell PB Jr; Vanderbilt University, Nashville, TN, USA., Marzac C; Institut Gustave-Roussy, Villejuif, France., Kelly P; Forma Therapeutics, Watertown, MA, USA., Sweeney J; Forma Therapeutics, Watertown, MA, USA., Forsyth S; Forma Therapeutics, Watertown, MA, USA., Guichard SM; Forma Therapeutics, Watertown, MA, USA., Brevard J; Forma Therapeutics, Watertown, MA, USA., Henrick P; Forma Therapeutics, Watertown, MA, USA., Mohamed H; Forma Therapeutics, Watertown, MA, USA., Cortes JE; Georgia Cancer Center, Augusta, GA, USA.

المصدر: The Lancet. Haematology [Lancet Haematol] 2023 Jan; Vol. 10 (1), pp. e46-e58. Date of Electronic Publication: 2022 Nov 10.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes*/drug therapy , Myelodysplastic Syndromes*/genetics , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Thrombocytopenia*/chemically induced , Thrombocytopenia*/drug therapy , Febrile Neutropenia*/drug therapy, Humans ; Female ; Male ; Azacitidine/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Isocitrate Dehydrogenase/genetics